The company is riding an incredible tailwind.

President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity ...

After a stunning Q1 earnings report and raised full-year guidance, the question is whether the valuation has run ahead of ...

Federal ethics disclosures published recently show President Donald Trump’s accounts purchased Eli Lilly stock on at least seven occasions in the first quarter of 2026 — a period in which his ...

Last year, Eli Lilly (NYSE: LLY) made history when it became the first healthcare company to reach a market cap of $1 ...

Eli Lilly exhibits strong bullish technicals, with price action, momentum, and relative strength all supporting a continued ...

After losing its market edge to Eli Lilly (NYSE: LLY) despite its first-mover advantage in weight-loss drugs, Novo Nordisk is ...

Eli Lilly is set to post earnings Thursday morning, with the stock seen potentially sinking to its lowest level in months following the report.

Eli Lilly (LLY 0.52%) just delivered another fantastic quarter, showcasing its impressive growth prospects. The company has ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

There's a reason the world's most patient investors love dividend stocks. Market movements heavily influence a stock's ...